Electrical impedance scanning (EIS) developer Mirabel Medical Systems (formerly known as TransScan) has closed a $9 million second round of funding. The Austin, TX-based firm said the investment will allow it to continue efforts to bring its T-Scan 2000 ED device to market over the next year.
The technology is designed to serve as an adjunct to a clinical breast exam in women ages 30 to 40 who typically have denser breast tissue. The device measures low-level electric signals as they pass through breast tissue, and identifies signal-flow patterns that are consistent with an increased risk for breast cancer, the company said.
By AuntMinnie.com staff writers
April 5, 2005
Related Reading
Road to RSNA, Mirabel Medical Systems, November 10, 2004
Copyright © 2005 AuntMinnie.com
